LEP and breast carcinoma: To explore other key regulatory molecules that are involved in leptin-induced EMT of breast cancer cells, gene expression chip array was conducted, which found that a series of enzymes related to glycometabolism increased in breast cancer cells, such as PGK1, PGAM2, PDK2, SUCLG1, DLST, and PKM2.